A detailed history of Advisors Capital Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Advisors Capital Management, LLC holds 13,681 shares of VRTX stock, worth $6.87 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
13,681
Previous 13,726 0.33%
Holding current value
$6.87 Million
Previous $5.74 Million 11.76%
% of portfolio
0.11%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$392.81 - $485.53 $17,676 - $21,848
-45 Reduced 0.33%
13,681 $6.41 Million
Q1 2024

May 06, 2024

SELL
$407.69 - $446.08 $949,510 - $1.04 Million
-2,329 Reduced 14.51%
13,726 $5.74 Million
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $944,622 - $1.13 Million
2,754 Added 20.71%
16,055 $6.53 Million
Q3 2023

Nov 15, 2023

BUY
$338.18 - $362.46 $4.5 Million - $4.82 Million
13,301 New
13,301 $4.63 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Advisors Capital Management, LLC Portfolio

Follow Advisors Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisors Capital Management, LLC with notifications on news.